Angiocentric cutaneous lymphoproliferative disorders
Bachelez, H.
Annales de Dermatologie et de Venereologie 127(1): 97-100
2000
ISSN/ISBN: 0151-9638 PMID: 10717574 Document Number: 523469
Document emailed within 1 workday
Related Documents
Kamihira, S.; Kinosita, K.; Ikeda, S.; Okabe, N. 1976: Cutaneous infiltration by neoplastic T-cells of patient with T-lymphoproliferative disorders of adult Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 39(2): 145-148Boggio, L.; Green, D. 2004: Coagulopathies associated with lymphoproliferative disorders Current Hematology Reports 3(1): 1-4
Ohtsu, T. 1996: Tumor markers in lymphoproliferative disorders Nihon Rinsho. Japanese Journal of Clinical Medicine 54(6): 1621-1625
Aguilar Escrivá, A.; Gómez Codina, J.; Munárriz Gandía, B. 1998: Post-transplant lymphoproliferative disorders Medicina Clinica 111(1): 32-36
Leoni, P.; Sprovieri, G.; Recchioni, A.; Orrico, C.; Olivieri, A. 1983: Beta 2-microglobulin in lymphoproliferative disorders Giornale di Clinica Medica 64(9-10): 315-325
Prochorec-Sobieszek, M.; Wagner, T. 2005: Lymphoproliferative disorders in Sjögren's syndrome Otolaryngologia Polska 59(4): 559-564
Akbari, C.M.; Welch, J.P.; Pastuszak, W. 1995: Primary lymphoproliferative disorders of the breast Connecticut Medicine 59(11): 651-655
Nalesnik, M.A.; Locker, J.; Jaffe, R.; Demetris, A.J.; Hartle, K.; Burnham, J.A.; Makowka, L.; Starzl, T.E. 1988: Clonal characteristics of posttransplant lymphoproliferative disorders Transplantation Proceedings 20(1 Suppl 1: 280-283
Sugai, S.; Takiguchi, T.; Konda, S. 1984: Monoclonal immunoglobulins and B cell lymphoproliferative disorders Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 47(8): 1604-1615
Williams, C.K. 1984: Management of malignant lymphoproliferative disorders of the nervous system African Journal of Medicine and Medical Sciences 13(3-4): 93-101
Boubenider, S.; Hiesse, C.; Goupy, C.; Kriaa, F.; Marchand, S.; Charpentier, B. 1997: Incidence and consequences of post-transplantation lymphoproliferative disorders Journal of Nephrology 10(3): 136-145
Zhu, P. 2006: Etiology, diagnosis, and treatment of post-transplant lymphoproliferative disorders Zhonghua Yi Xue Za Zhi 86(42): 2957-2958
Oda, D.; Persson, G.R.; Haigh, W.G.; Sabath, D.E.; Penn, I.; Aziz, S. 1996: Oral presentation of posttransplantation lymphoproliferative disorders. An unusual manifestation Transplantation 61(3): 435-440
Colita, A.; Colita, A.; Moise, L.; Arion, C.; Popescu, I. 2012: Post-transplant lymphoproliferative disorders after solid organ transplantation in children Chirurgia 107(4): 431-437
Wan, J.H. 1990: Use of polymerase chain reaction (PCR) to detect monoclonality of B-lymphoproliferative disorders at DNA level Zhonghua Zhong Liu Za Zhi 12(4): 242-245
Jakubowicz, K.; Kik, A. 1982: Current classification of malignant lymphoproliferative disorders (lymphoma) from the dermatological viewpoint Przeglad Dermatologiczny 69(1-2): 1-7
Solivetti, F.; Spadea, A.; Brigida, R.; Pisani, F.; Petti, M.C. 2006: Doppler flowmetry of splenic vessels in lymphoproliferative disorders: preliminary results Journal of Experimental and Clinical Cancer Research: Cr 25(3): 453-455
Houston, J.G.; Keene, W.R. 1970: Exaggerated delayed hypersensitivity to mosquito venom in association with lymphoproliferative disorders Journal of the Florida Medical Association 57(12): 15-17
Katz, J.; Lea, R.; Livni, N.; Lewis, D.; Lynch, S.R.; Skikne, B.; Bezwoda, W. 1978: B- and T-cell markers in lymphoproliferative disorders with blood and bone marrow involvement South African Medical Journal 53(20): 789-792
Gupta, S.; Good, R.A. 1980: Markers of human lymphocyte subpopulations in primary immunodeficiency and lymphoproliferative disorders Seminars in Hematology 17(1): 1-29